KARO vs AMN vs IOT Stock Comparison

Karooooo, Amn Healthcare Services and Samsara Prices as of Oct 27, 2026 Peers: Industry group
1 more company in this comparison (ITRN) Create a free account to keep reading and compare up to 10 companies.
KARO Karooooo Ltd.
$64.46 +4.6% 1M +40.8% 1Y
Market cap
$2.03B
P/E
31.6x
Revenue (TTM)
$364.50M
Div. yield
–
Supply Chain Software Technology
6 wins
IOT Samsara Inc.
$43.51 +14.5% 1M +9.0% 1Y
Market cap
$25.06B
P/E
276.7x
Revenue (TTM)
$1.85B
Div. yield
–
Supply Chain Software Technology
1 win

Head to Head

10 decided of 12

Karooooo leads on 6 of the 12 questions below (Karooooo 6, Amn Healthcare Services 3, Samsara 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionKAROAMNIOTLeader
Larger companyMarket capitalisation $2.03B $1.83B $25.06B IOT
Cheaper on earningsLower P/E, profitable companies only 31.6x 17.4x 276.7x AMN
Cheaper on forward earningsLower price / next fiscal year consensus EPS 26.2x 14.7x 53.7x AMN
Faster revenue growthRevenue growth, trailing twelve months +31.4% +24.0% +29.5% KARO
More profitableNet margin, trailing twelve months 17.6% 3.1% 4.9% KARO
Better return on capitalReturn on invested capital 34.9% 8.7% — KARO
Less leveragedLower net debt / EBITDA — 1.1x — –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +40.8% +122.5% +9.0% AMN
Better 5-year returnAnnualised price return, 5 years +13.0%/yr -14.0%/yr — KARO
Less volatileAnnualised volatility, 1 year 36.5% 64.2% 59.6% KARO
Higher overall scoreMean of the five percentile scores vs peers 70/100 68/100 52/100 KARO

Percentile Scorecard

KAROAMNIOT

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisKAROAMNIOT
Valuation 60 #36 of 89 95 #7 of 112 14 #77 of 89
Growth 81 #16 of 81 57 #42 of 96 99 #2 of 81
Profitability 100 #1 of 76 66 #32 of 91 60 #31 of 76
Financial Health 57 #41 of 94 54 #58 of 125 59 #39 of 94
Shareholder Returns 52 #25 of 51 – 30 #36 of 51
Overall 70 68 52
  • KARO ranked among 98 companies in Vertical Software
  • AMN ranked among 130 companies in Business Services
  • IOT ranked among 98 companies in Vertical Software

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodKAROAMNIOTSPY
1 month +4.6%+35.1%+14.5% -0.2%
3 months +0.8%+34.9%+16.0% +3.9%
6 months +28.9%+123.4%+48.3% +8.2%
Year to date +41.7%+196.6%+22.7% +12.9%
1 year +40.8%+122.5%+9.0% +12.3%
3 years +193.4%-38.2%+95.9% +87.4%
3 years, per year +43.2%-14.9%+25.1% +23.3%
5 years +84.2%-52.9%— +67.9%
5 years, per year +13.0%-14.0%— +10.9%
10 years —+47.1%— +261.1%
10 years, per year —+3.9%— +13.7%

Risk

MeasureKAROAMNIOTSPY
Volatility, 1Y 36.5%64.2%59.6% 12.7%
Downside volatility, 1Y 32.1%55.0%55.2% 12.7%
Beta vs S&P 500, 1Y 0.920.760.80 1.00
Return / volatility, 1Y 1.121.910.15 0.97
Max drawdown, 5Y -54.4%-88.1%-70.4% -25.4%
From 52-week high -6.2%-4.7%-3.8% -1.2%
52-week high $68.71$49.05$45.22 $779.14
52-week low $41.60$15.10$24.25 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleKAROAMNIOT
P/E now vs peer median 31.1xmedian 40.1x 17.4xmedian 21.2x 280.7xmedian 40.1x
P/S now vs peer median 5.5xmedian 2.5x 0.5xmedian 0.9x 13.8xmedian 2.5x
EV/EBITDA now vs peer median —median 18.5x 6.3xmedian 11.9x 500.6xmedian 18.5x
P/FCF now vs peer median 15.4xmedian 20.1x 4.1xmedian 13.7x 99.7xmedian 20.1x
P/B now vs peer median 10.3xmedian 1.8x 2.4xmedian 2.4x 15.9xmedian 1.8x
PEG now vs peer median —median 1.73 -0.56median 1.00 8.57median 1.73

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsKAROAMNIOT
Revenue $364.50M $3.43B $1.85B
Gross profit $245.35M $954.26M $1.41B
Operating income $92.48M $199.82M $19.37M
Net income $65.09M $104.92M $90.55M
Free cash flow $129.31M $439.13M $255.48M
R&D $16.89M – $375.86M
EPS (diluted) – $2.64 $0.15
Cash & equivalents $40.11M $361.84M $291.39M
Total debt $171.74M $3.10B –
Shares (diluted) – 39.73M 590.46M
Enterprise value $1.69B $818.56M $21.83B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricKAROAMNIOT
P/E 31.1x 17.4x 280.7x
P/FCF 15.4x 4.1x 99.7x
P/Operating cash flow 15.4x 3.8x 88.3x
P/S 5.5x 0.5x 13.8x
P/B 10.3x 2.4x 15.9x
P/Tangible book 10.3x 3.7x 15.9x
EV/EBITDA – 6.3x 500.6x
EV/EBIT 21.5x 11.0x 1,272x
EV/Revenue 5.4x 0.6x 13.3x
EV/FCF 15.3x 5.0x 96.4x
EV/Operating cash flow 15.3x 4.7x 85.4x
PEG (3Y EPS CAGR) – -0.56 8.57

Growth

14 metrics
MetricKAROAMNIOT
Revenue growth (1Y) 31.4% 24.0% 29.5%
Revenue CAGR (3Y) 19.1% -7.8% 33.3%
Gross profit growth (1Y) 27.8% 15.4% 28.7%
Gross profit CAGR (3Y) 21.6% -13.2% 35.7%
Operating income growth (1Y) 17.7% 168.5% 115.4%
Operating income CAGR (3Y) 21.9% -25.0% 27.5%
Net income growth (1Y) 15.9% 135.2% 203.0%
Net income CAGR (3Y) 22.6% -31.0% 33.5%
EPS growth (1Y) – 134.1% 199.7%
EPS CAGR (3Y) – -31.2% 32.8%
Operating cash flow growth (1Y) 45.0% 51.5% 49.7%
Operating cash flow CAGR (3Y) 24.4% 0.0% 581.0%
Free cash flow growth (1Y) 45.0% 71.9% 50.6%
Free cash flow CAGR (3Y) 31.7% 4.8% 142.3%

Profitability

14 metrics
MetricKAROAMNIOT
Gross margin 67.3% 27.8% 76.4%
EBITDA margin – 10.1% 2.7%
Operating margin 25.4% 5.8% 1.0%
Pretax margin 24.2% 4.8% 5.6%
Net margin 17.6% 3.1% 4.9%
FCF margin 35.5% 12.8% 13.8%
Operating cash flow margin 35.5% 13.7% 15.6%
Return on equity 31.3% 14.4% 5.8%
Return on assets 16.8% 4.2% 3.4%
Return on invested capital 34.9% 8.7% –
Return on capital employed 38.5% 11.7% 1.1%
Asset turnover 0.9x 1.4x 0.7x
Cash conversion (OCF / net income) 2.0x 4.5x 3.2x
Stock comp / revenue – 0.9% 17.9%

Financial Health

11 metrics
MetricKAROAMNIOT
Debt / assets 17.4% 31.4% –
Debt / equity 0.3x 1.0x –
Net debt / EBITDA – 1.1x –
Debt / FCF 0.5x 1.7x –
Liabilities / assets 50.2% 68.6% 42.1%
Equity / assets 49.8% 31.4% 57.9%
Interest coverage 14.9x 5.6x –
Current ratio 0.6x 1.1x 1.6x
Quick ratio 0.9x 1.0x 1.2x
Cash ratio 0.5x 0.5x 0.9x
Altman Z-score 8.21 3.22 13.26

Shareholder Returns

7 metrics
MetricKAROAMNIOT
Dividend yield 2.3% – –
Net buyback yield – – -0.1%
Shareholder yield 2.3% – -0.1%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusKAROAMNIOT
Forward P/E 26.2xFY2026 14.7xFY2026 53.7xFY2026
EPS, next fiscal year $2.46FY2026 $3.18FY2026 $0.81FY2026
EPS growth, next FY +21.2%FY2026 +133.8%FY2026 +44.6%FY2026
EPS growth, the year after +16.7% -69.8% +23.5%
Revenue, next fiscal year $418.13MFY2026 $3.49BFY2026 $1.93BFY2026
Revenue growth, next FY +22.3%FY2026 +28.0%FY2026 +19.3%FY2026
Revenue growth, the year after +3.1% -28.4% +30.8%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersKAROAMNIOT
Held by institutions 14.4% 100.0% 100.0%
Institutions holding 83 286 549
Change in shares held, QoQ +18.4% +8.0% +9.1%
Institutions buying 54 182 318
Institutions selling 13 76 165
Buyers to sellers 4.15 2.39 1.93

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

KAROAMNIOT
KARO 1.00 0.10 0.41
AMN 0.10 1.00 0.13
IOT 0.41 0.13 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, KARO, AMN and IOT?

Samsara (IOT) is the largest by market capitalisation: Karooooo (KARO) $2.03B, Amn Healthcare Services (AMN) $1.83B, Samsara (IOT) $25.06B.

Which stock is cheaper, KARO, AMN and IOT?

Amn Healthcare Services (AMN) trades on the lowest price-to-earnings ratio (Karooooo (KARO) 31.6x, Amn Healthcare Services (AMN) 17.4x, Samsara (IOT) 276.7x). On next year's consensus earnings, Amn Healthcare Services (AMN) is cheapest (Karooooo (KARO) 26.2x, Amn Healthcare Services (AMN) 14.7x, Samsara (IOT) 53.7x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Karooooo (KARO) grew revenue fastest over the trailing twelve months: Karooooo (KARO) +31.4%, Amn Healthcare Services (AMN) +24.0%, Samsara (IOT) +29.5%.

Which company is more profitable?

Karooooo (KARO) has the highest net margin (Karooooo (KARO) 17.6%, Amn Healthcare Services (AMN) 3.1%, Samsara (IOT) 4.9%). On return on invested capital, Karooooo (KARO) leads (Karooooo (KARO) 34.9%, Amn Healthcare Services (AMN) 8.7%).

Which stock has performed better?

Over the past year Amn Healthcare Services (AMN) returned the most: Karooooo (KARO) +40.8%, Amn Healthcare Services (AMN) +122.5%, Samsara (IOT) +9.0%. Over five years, Karooooo (KARO) compounded fastest (Karooooo (KARO) +13.0%/yr, Amn Healthcare Services (AMN) -14.0%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Karooooo (KARO) has been the steadiest (Karooooo (KARO) 36.5%, Amn Healthcare Services (AMN) 64.2%, Samsara (IOT) 59.6%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, KARO, AMN and IOT?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Karooooo (KARO) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.